Table 2.
Baseline characteristics of the study participants
| Characteristica | Total | MD-C/PT-C | MD-C/PT-I | MD-I/PT-C | MD-I/PT-I |
|---|---|---|---|---|---|
| n | 574 | 141 | 140 | 148 | 145 |
| Age, yr | 60.6 (11.1) | 60.9 (11.8) | 59.4 (12.0) | 61.6 (10.2) | 60.4 (10.5) |
| BMI, Kg/m2 | 32.6 (5.5) | 32.9 (5.7) | 31.8 (5.5) | 32.7 (5.5) | 33.1 (5.3) |
| SBP, mmHg | 132.8 (16.1) | 132.2 (15.0) | 131.1 (17.9) | 133.8 (14.2) | 134.0 (17.3) |
| DBP, mmHg | 73.8 (11.1) | 73.9 (10.7) | 71.6 (11.7) | 74.1 (11.0) | 75.6 (11.0) |
| Female, # (%) | 297 (62) | 74 (64) | 80 (71) | 76 (58) | 67 (56) |
| African American, # (%) | 182 (38) | 50 (43) | 48 (42) | 41 (31) | 43 (36) |
| Adequate Income, # (%) | 390 (85) | 92 (84) | 91 (86) | 111 (89) | 96 (82) |
| Education, completed high school, # (%) | 440 (93) | 106 (93) | 105 (95) | 119 (92) | 110 (92) |
| Hypertension, # (%) | 462 (96) | 114 (98) | 110 (97) | 126 (96) | 112 (93) |
| Medication adherence, # (%) | 369 (83) | 81 (79) | 85 (83) | 111 (88) | 92 (81) |
a
All values are expressed as either Mean (SD) or #(%). MD-C: Physician control, PT-C: patient control, MD-I: Physician intervention, PT-I: Patient intervention. There are no significant differences in the characteristics among the treatment groups.